Reduction in Thrombolytic Usage in Hemodialysis Patients Following a Quality Assurance Review: A Research Letter

BACKGROUND: Catheter malfunction in hemodialysis (HD) is increasingly managed with recombinant tissue plasminogen activator (rt-PA, alteplase), though evidence of improved catheter function is lacking. OBJECTIVE: To evaluate the effect of a standardized rt-PA administration protocol on rt-PA usage,...

Descripción completa

Detalles Bibliográficos
Autores principales: Bau, Jason T., Younis, Kokab, Gallagher, Nathen, Harrison, Tyrone G., Leung, Kelvin, Hemmett, Juliya, Qirjazi, Elena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Clinical Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10214048/
https://www.ncbi.nlm.nih.gov/pubmed/37251299
http://dx.doi.org/10.1177/20543581231174276

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10214048/
https://www.ncbi.nlm.nih.gov/pubmed/37251299
http://dx.doi.org/10.1177/20543581231174276

Ejemplares similares